Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"

Musculoskeletal Report: Rheumatology, Dermatology, and Orthopedics

Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"

Found on page: 9

Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"MSKReport presents an important series of talks from the International Society of Extremity MRI in Rheumatology (ISEMIR). The fourth episode, from Dr. Charles Peterfy discusses the use of MRI as an outcomes measure for clinical trials.

» See All EpisodesEpisodes of This Videocast:

Pages: 12 3 4 5 » 19

ACR 2008: Efficacy of Tadalafil in Secondary Raynaud’s Phenomenon Resistant to Vasodilator Therapy: A Double Blind Randomized Cross Over Trial
Posted: 2008-10-31 07:00:00
Dr. Padmanabha Shenoy of Sanjay Gandhi Post Graduate Institute of Medical Sciences presents "Efficacy of Tadalafil in Secondary Raynaud’s Phenomenon R [more...]

Dr. Padmanabha Shenoy of Sanjay Gandhi Post Graduate Institute of Medical Sciences presents "Efficacy of Tadalafil in Secondary Raynaud’s Phenomenon Resistant to Vasodilator Therapy: A Double Blind Randomized Cross Over Trial" at the 2008 Annual Scientific Meeting of the American College of Rheumatology
ACR 2008: Hydroxychloroquine Use Reduces Risk Of Diabetes In Rheumatoid Arthritis Patients
Posted: 2008-10-31 07:00:00
Dr. Androniki Bili of Geisinger Medical Center presents "Hydroxychloroquine Use Reduces Risk Of Diabetes In Rheumatoid Arthritis Patients" at the 2008 [more...]

Dr. Androniki Bili of Geisinger Medical Center presents "Hydroxychloroquine Use Reduces Risk Of Diabetes In Rheumatoid Arthritis Patients" at the 2008 Annual Scientific Meeting of the American College of Rheumatology
ACR 2008: A multicentric, double-blind trial of Anakinra versus placebo in Systemic Onset Juvenile Idiopathic Arthritis (ANAJIS trial): efficacy and tolerance over 12 months
Posted: 2008-10-31 07:00:00
Dr. Pierre Quartier of Hopital Necker-Enfants Malades, Paris, France presents " A multicentric, double-blind trial of Anakinra versus placebo in Syste [more...]

Dr. Pierre Quartier of Hopital Necker-Enfants Malades, Paris, France presents " A multicentric, double-blind trial of Anakinra versus placebo in Systemic Onset Juvenile Idiopathic Arthritis (ANAJIS trial): efficacy and tolerance over 12 months" at the 2008 Annual Scientific Meeting of the American College of Rheumatology
ACR 2008: Protective Effect of Hydroxychloroquine (HCQ) on Renal Damage in Patients with Systemic Lupus Erythematosus (SLE): Data from a Multiethnic Cohort
Posted: 2008-10-31 07:00:00
Dr. Graciela S. Alarcon of University of Alabama at Birmingham presents "Protective Effect of Hydroxychloroquine (HCQ) on Renal Damage in Patients wit [more...]

Dr. Graciela S. Alarcon of University of Alabama at Birmingham presents "Protective Effect of Hydroxychloroquine (HCQ) on Renal Damage in Patients with Systemic Lupus Erythematosus (SLE): Data from a Multiethnic Cohort" at the 2008 Annual Scientific Meeting of the American College of Rheumatology

Pages: 12 3 4 5 » 19

Get the Flash Player to see this video.

Advanced Options

[add tags]Tag It:

Rate it:

tag 1

User comments for Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"

Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"

Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"

» See All EpisodesEpisodes of This Videocast:

ACR 2008: Efficacy of Tadalafil in Secondary Raynaud’s Phenomenon Resistant to Vasodilator Therapy: A Double Blind Randomized Cross Over Trial

ACR 2008: Hydroxychloroquine Use Reduces Risk Of Diabetes In Rheumatoid Arthritis Patients

ACR 2008: A multicentric, double-blind trial of Anakinra versus placebo in Systemic Onset Juvenile Idiopathic Arthritis (ANAJIS trial): efficacy and tolerance over 12 months

ACR 2008: Protective Effect of Hydroxychloroquine (HCQ) on Renal Damage in Patients with Systemic Lupus Erythematosus (SLE): Data from a Multiethnic Cohort

[add tags]Tag It:

Rate it:

» More Related EpisodesRelated Episodes:

User comments for Dr. Charles Peterfy presents "MRI as an Entry and Outcome Measure for RA Clinical Trials"

Submit a Comment